Biocorp: takeover by Novo Nordisk completed
The outstanding convertible bonds issued by Biocorp were redeemed in full in cash on this occasion, and the composition of Biocorp's Board of Directors was modified to take account of the new shareholder structure.
Novo Nordisk will file with the AMF in the next few days a proposed simplified tender offer (OPAS) to acquire the remaining shares, followed by a squeeze-out if the required conditions are met.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction